scholarly journals Effectiveness of National Residential Smoking Cessation Program

2021 ◽  
Vol 18 (18) ◽  
pp. 9901
Author(s):  
Mi-Jeong Park ◽  
Young-Gyun Seo ◽  
Hye-Mi Noh ◽  
Yeol Kim ◽  
Jong Lull Yoon ◽  
...  
Keyword(s):  
Smoking Cessation ◽  
Combination Therapy ◽  
Nicotine Dependence ◽  
Self Efficacy ◽  
Therapy Group ◽  
Smoking Cessation Program ◽  
Short Term ◽  
Factors Affecting ◽  
Urine Cotinine ◽  
Continuous Abstinence

We aimed to investigate the effectiveness of the Korean national five-day residential smoking cessation program and the factors affecting the long-term smoking cessation of participants. The residential smoking cessation program (2017–2018) recruited smokers with a smoking duration ≥ 20 years and who have attempted to quit smoking more than twice and/or smokers with chronic morbidities. Participants underwent an intensive intervention, including individual psychological therapy, group therapy, medical counseling, and pharmacotherapy. The 6-month continuous abstinence rate (CAR) was assessed via self-reports, the urine cotinine levels, and/or expired-air carbon monoxide levels. Logistic regression was used to analyze the adjusted odds ratio (aOR) to assess factors related to smoking cessation. Overall, 484 participants who completed the residential program and questionnaire were evaluated. The 3- and 6-month CAR were 81.82% and 63.22%, respectively. The aOR of 6-month continuous abstinence was lower among participants with severe nicotine dependence (aOR: 0.46, 95% confidence interval [CI]: 0.26–0.81) and higher among participants with combination therapy of varenicline with short-term nicotine replacement therapy (NRT) (aOR: 1.64, 95% CI: 1.07–2.51), with higher self-efficacy (aOR: 1.97, 95% CI: 1.15–3.37). The residential smoking cessation program was effective. High self-efficacy, combination therapy of varenicline with short-term NRT, and low nicotine dependence were associated with a high 6-month CAR.

scholarly journals Effects of morbidity on smoking cessation: a national smoking cessation program

2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Young-Gyun Seo ◽  
Min-Woo Jo ◽  
Yu-Jin Paek ◽  
Jaekyung Choi
Keyword(s):  
Smoking Cessation ◽  
Chronic Diseases ◽  
National Health ◽  
Smoking Cessation Program ◽  
Chronic Obstructive ◽  
Cluster Sampling ◽  
Affecting Factors ◽  
Obstructive Pulmonary Disease ◽  
Factors Affecting ◽  
Continuous Abstinence

Abstract Background In smokers with chronic diseases, we examined the abstinence rates over 6 months and its affecting factors in the context of the Korea National Health Insurance Service (NHIS) smoking cessation program. Methods To identify 6-month abstinence, we extracted a sample of 15,017 participants using the multi-stage stratified cluster sampling method from the 359,047 individuals enrolled in the 2016 NHIS smoking cessation program and 1500 smokers responded to the telephone survey. From this group, 1245 individuals (48.50 ± 12.55 years; men 89.8%) were enrolled, as they had no missing information for confounding variables. We compared chronic disease distribution between participants and current smokers in the 2016 Korea National Health and Nutrition Examination Survey. We evaluated the factors affecting continuous abstinence rate (CAR) across patients with different chronic diseases: hypertension, diabetes mellitus (DM), dyslipidemia (DL), chronic obstructive pulmonary disease, and major depressive disorder (MDD). Results While participation of DM patients was high, the participation of DL patients was relatively low. The CAR over 6 months was 44.74%. The adjusted odds ratio (OR) for continuous abstinence over 6 months was significantly lower in the MDD group than in the no-MDD group (OR 0.43, 95% confidence interval [CI] 0.21 to 0.85). The factors of program completion (complete versus incomplete: OR 3.11, 95% CI 2.43 to 3.98), region (non-metropolitan areas versus Seoul metropolitan area: OR 1.28, 95% CI 1.01 to 1.61), and nicotine dependence (severe versus light or moderate: OR 0.64, 95% CI 0.50 to 0.83) were significantly associated with CAR. Conclusions The smoking cessation program was not actively recruiting smokers with chronic diseases. The CARs in each disease group were not different from those in the non-disease groups, except that the MDD group had a lower CAR over 6 months than the no-MDD group. Recruiting smokers with chronic diseases and improving their CARs depends on the careful identification of their characteristics.

Psychological changes in successful completers of an HIV-tailored smoking cessation program: mood, attachment and self-efficacy

AIDS Care ◽  
2021 ◽  
pp. 1-9
Author(s):  
Stephanie A. Wiebe ◽  
Louise Balfour ◽  
William D. Cameron ◽  
Daniella Sandre ◽  
Crystal Holly ◽  
...  
Keyword(s):  
Smoking Cessation ◽  
Self Efficacy ◽  
Smoking Cessation Program ◽  
Psychological Changes

Self-efficacy mediates treatment outcome in a smoking cessation program for adolescent smokers

2015 ◽  
Vol 146 ◽  
pp. e100 ◽  
Author(s):  
Patricia Simon ◽  
Christian Connell ◽  
Grace Kong ◽  
Meghan E. Morean ◽  
Dana A. Cavallo ◽  
...  
Keyword(s):  
Smoking Cessation ◽  
Treatment Outcome ◽  
Self Efficacy ◽  
Smoking Cessation Program ◽  
Adolescent Smokers

Pharmacist-Delivered Smoking Cessation Program in Community Pharmacy (The FINE Program) in Japan—The Development of a Training Course and a Feasibility Study

2019 ◽  
pp. 089719001988974
Author(s):  
Mitsuko Onda ◽  
Takashi Kuwanoe ◽  
Atsunori Hashimoto ◽  
Michiko Horiguchi ◽  
Masayuki Domichi ◽  
...  
Keyword(s):  
Smoking Cessation ◽  
Community Pharmacy ◽  
Feasibility Study ◽  
Smoking Status ◽  
Controlled Trial ◽  
Smoking Cessation Program ◽  
Community Pharmacies ◽  
The Family ◽  
Quitting Smoking ◽  
Continuous Abstinence

Aim: Although smoking cessation support has been recommended as a routine component of pharmacists’duties, there is limited evidence of smoking cessation being achieved successfully in community pharmacy. The aim of this study was to develop a new smoking cessation program for use in the community pharmacy setting and investigate its feasibility. Methods: A feasibility study (the Family pharmacist’s Intervention for Nicotine Elimination [FINE] program) was conducted using 8 pharmacists at 2 community pharmacies in Japan. The pharmacists recruited as subjects smokers 20 or more years of age who were taking medications such as antidiabetes drugs. The patients completed questionnaires assessing their smoking status, and the pharmacists provided them with smoking cessation support services. Participating patients met with the pharmacists or talked to them on the phone 5 times at 2- to 4-week intervals and received personalized and structured brief smoking cessation advice. The primary outcome was continuous abstinence determined by Micro Smokerlyzer carbon monoxide monitor at 3 months. Results: Of 5306 patients, 2296 patients were screened and the rate of smoking was found to be 12.7%. Five smoking patients received the FINE program from pharmacists who had received training. One of the 5 succeeded in quitting smoking after 3 months. Conclusions: This is the first study to target Japanese smoking patients in community pharmacies with a brief structured intervention. The results tentatively support the feasibility of the FINE program. Further research including a randomized controlled trial is required to confirm the effectiveness of the FINE program.

Evaluation of a Pharmacist and Nurse Practitioner Smoking Cessation Program

2016 ◽  
Vol 30 (4) ◽  
pp. 406-411 ◽  
Author(s):  
Zubair Afzal ◽  
Elizabeth Pogge ◽  
Virginia Boomershine
Keyword(s):  
Smoking Cessation ◽  
Medication Adherence ◽  
Nicotine Dependence ◽  
Nurse Practitioner ◽  
Point Prevalence ◽  
Smoking Cessation Program ◽  
Prevalence Rates ◽  
Smoking Cessation Counseling ◽  
Face To Face ◽  
Study Completion

Purpose: To evaluate the efficacy of a smoking cessation program led by a pharmacist and a nurse practitioner. Methods: During a 6-month period, patients attended 7 one-on-one face-to-face smoking cessation counseling sessions with a pharmacist and 1 to 2 one-on-one face-to-face smoking cessation counseling sessions with a nurse practitioner. The primary outcome was smoking cessation point prevalence rates at months 1, 3, and 5 post-quit date. Secondary outcomes included medication adherence rates at months 1, 3, and 5 post-quit date, nicotine dependence at baseline versus program end, and patient satisfaction. Results: Nine (47%) of 19 total participants completed the program. Seven of the 9 patients who completed the program were smoke-free upon study completion. Point prevalence rates at months 1, 3, and 5 post-quit date were 66%, 77%, and 77%, respectively, based on patients who completed the program. Medication adherence rates were 88.6%, 54.6%, and 75% at months 1, 3, and 5 post-quit date, respectively. Based on the Fagerstrom test, nicotine dependence decreased from baseline to the end of the study, 4.89 to 0.33 ( P < .001). Overall, participants rated the program highly. Conclusion: A joint pharmacist and nurse practitioner smoking cessation program can assist patients in becoming smoke-free.

Smoking cessation according to nicotine dependence: experience of a smoking cessation program

2020 ◽  
Author(s):  
Joana Raquel Monteiro Ferra ◽  
Ana Cláudia Vieira ◽  
Inês Oliveira ◽  
Joana Carvalho ◽  
Cristina Matos ◽  
...  
Keyword(s):  
Smoking Cessation ◽  
Nicotine Dependence ◽  
Smoking Cessation Program
Sign in / Sign up

Export Citation Format

Share Document